LRMR icon

Larimar Therapeutics
LRMR

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$14.25
235% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Andreas Argyrides
50% 1-yr LRMR win rate
2 Oct ‘25 14 days ago
Wedbush
Wedbush
Laura Chico
100% 1-yr LRMR win rate
30 Sep ‘25 16 days ago
Baird
Baird
Joel Beatty
100% 1-yr LRMR win rate
30 Sep ‘25 16 days ago
JMP Securities
JMP Securities
Jonathan Wolleben
50% 1-yr LRMR win rate
19 Aug ‘25 1 month ago